Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Catecholamine levels are further increased by glucocorticoids, which block the transporters on glia that normally remove catecholamines from the extracellular space.
“Catecholamine levels are further increased by glucocorticoids, which block the transporters on glia that normally remove catecholamines from the extracellular space51.”
From Stress weakens prefrontal networks: molecular insults to higher cognition (2015) · cites this paper as [51]
Cited by
Sorted by citations
Stress signalling pathways that impair prefrontal cortex structure and function
Arnsten, A. F. T. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2648 · Cited by 3,299 · see citing works
Koepsell, H., Lips, K. S., & Volk, C. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9254-z · Cited by 984 · see citing works
“Histamine (>20,000) 940, 13,00 180, 220 (63,103–105) Norepinephrine (7,100) 1,500, 1,900 510–2,600 (21,63,105)”
Xenobiotic, Bile Acid, and Cholesterol Transporters: Function and Regulation
Klaassen, C. D., & Aleksunes, L. M. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002014 · Cited by 808 · see citing works
“Oct3 is also called the extraneuronal monoamine transporter and participates in the uptake of extraneuronal monoamines in peripheral tissues and glia cells (also known as the uptake-2 system) (Gründemann et al., 1998; Wu et al., 1998).”
BackgroundStress weakens prefrontal networks: molecular insults to higher cognition
Arnsten, A. F. T. (2015) · Nature Neuroscience · doi:10.1038/nn.4087 · Cited by 752 · see citing works
Roth, M. E., Obaidat, A., & Hagenbuch, B. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01724.x · Cited by 764 · see citing works
“OCT1 and OCT2 have 70% amino acid identity to each other, and approximately 50% identity with OCT3 (Gorboulev et al., 1997; Zhang et al., 1997; Grundemann et al., 1998).”
BackgroundMethodSun, D., Luo, M., Jeong, M., Rodriguez, B., Xia, Z., Hannah, R., Wang, H., Le, T., Faull, K. F., Chen, R., et al. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.03.002 · Cited by 686 · see citing works
“To test whether their decreased expression might explain HSC aging phenotypes, we selected the imprinted gene Slc22a3 encoding a solute carrier family member (Gründemann et al., 1998), for further characterization (Figure 7B).”
MethodQin, S., Hermans, E. J., van Marle, H. J. F., Luo, J., & Fernández, G. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.03.006 · Cited by 675 · see citing works
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 549 · see citing works
The SLC22 drug transporter family
Koepsell, H., & Endou, H. (2004) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-003-1089-9 · Cited by 521 · see citing works
“For example, hOCT3 translocates TEA, MPP, guanidine, dopamine, norepinephrine, and histamine [18, 22, 62].”
BackgroundCarrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?
Dobson, P. D., & Kell, D. B. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2438 · Cited by 475 · see citing works
Organic cation transporters are determinants of oxaliplatin cytotoxicity.
Zhang, S., Lovejoy, K. S., Shima, J. E., Lagpacan, L. L., Shu, Y., Lapuk, A., Chen, Y., Komori, T., Gray, J., Chen, X., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0769 · Cited by 426 · see citing works
“OCT3 is expressed in many tissues, including placenta, heart, liver, and skeletal muscle (24, 25).”
BackgroundThe SLC22 family with transporters of organic cations, anions and zwitterions
Koepsell, H. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.10.010 · Cited by 390 · see citing works
“The Slc22a3/SLC22A3 gene encoding OCT3 in rat and human were cloned in the same year (Gründemann et al., 1998; Kekuda et al., 1998).”
BackgroundJonker, J., & Schinkel, A. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.053298 · Cited by 393 · see citing works
“It was independently cloned by two different groups and was designated EMT/OCT3 (Kekuda et al., 1998; Wu et al., 1998; Gründemann et al., 1998).”
BackgroundInfluentialNies, A. T., Koepsell, H., Winter, S., Burk, O., Klein, K., Kerb, R., Zanger, U. M., KEPPLER, D. O. R., Schwab, M. G., & Schaeffeler, E. (2009) · Hepatology · doi:10.1002/hep.23103 · Cited by 382 · see citing works
Roozendaal, B., Okuda, S., de Quervain, D. J.-F., & McGaugh, J. L. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.07.049 · Cited by 382 · see citing works
Nies, A. T., Koepsell, H., Damme, K., & Schwab, M. G. (2010) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-14541-4_3 · Cited by 373 · see citing works
Eisenhofer, G. (2001) · Pharmacology and Therapeutics · doi:10.1016/s0163-7258(01)00144-9 · Cited by 373 · see citing works
Choline Transport for Phospholipid Synthesis
Michel, V., Yuan, Z.-F., Ramsubir, S., & Bakovic, M. (2006) · Experimental biology and medicine · doi:10.1177/153537020623100503 · Cited by 330 · see citing works
Roozendaal, B., McReynolds, J. R., & McGaugh, J. L. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4664-03.2004 · Cited by 327 · see citing works
“…levels in the mPFC (Thomas et al., 1994) by stimulating GRs in noradrenergic cell populations in the brainstem (Härfstrand et al., 1987; McEwen, 1987; Roozendaal et al., 1999b) or by locally blocking extraneuronal norepinephrine reuptake mechanisms in the mPFC (Grundemann et al., 1998).”
BackgroundCognitive emotion regulation fails the stress test
Raio, C. M., Orederu, T. A., Palazzolo, L., Shurick, A. A., & Phelps, E. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305706110 · Cited by 302 · see citing works
“It has been suggested that cortisol may preserve or exaggerate the effects of catecholamines by inhibiting their clearance from the PFC, thus altering their brain concentration (20, 29, 33, 46).”
BackgroundRoozendaal, B., Hahn, E. L., Nathan, S. V., de Quervain, D. J.-F., & McGaugh, J. L. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2574-04.2004 · Cited by 301 · see citing works
“, 2001), and glucocorticoids may increase norepinephrine levels by locally blocking extraneuronal norepinephrine reuptake mechanisms (Grundemann et al., 1998).”
BackgroundImmunolocalization of the cocaine- and antidepressant-sensitive l-norepinephrine transporter
Schroeter, S., Apparsundaram, S., Wiley, R. G., Miner, L. H., Sesack, S. R., & Blakely, R. (2000) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(20000501)420:2 · Cited by 277 · see citing works
Hayer-Zillgen, M., Brüss, M., & Bönisch, H. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704785 · Cited by 292 · see citing works
“Finally, species di erences have also been described for the OCT3: while the rat OCT3 transports MPP+ and the prototypic organic cation TEA (Kekuda et al., 1998), virtually no transport of TEA could be demonstrated for the human homologue (GruÈ ndemann et al., 1998).”
BackgroundMethodInfluentialDresser, M., Leabman, M. K., & Giacomini, K. (2001) · Journal of Pharmacy and Science · doi:10.1002/1520-6017(200104)90:4 · Cited by 285 · see citing works
Birnbaum, S., Gobeske, K. T., Auerbach, J., Taylor, J. R., & Arnsten, A. F. T. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00138-9 · Cited by 281 · see citing works
Identification and Characterization of a Novel Monoamine Transporter in the Human Brain*
Engel, K., Zhou, M.-Y., & Wang, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407913200 · Cited by 274 · see citing works
Jonker, J., Wagenaar, E., van Eijl, S., & Schinkel, A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.21.7902-7908.2003 · Cited by 270 · see citing works
“Previously, it has been shown that MPP is transported in vitro and in vivo by Oct1 (13, 20) and in vitro by Oct2 (6).”
BackgroundInfluentialDrug specificity and intestinal membrane localization of human organic cation transporters (OCT).
Müller, J., Lips, K., Metzner, L., Neubert, R., Koepsell, H., & Brandsch, M. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.09.011 · Cited by 268 · see citing works
The Complexities of Hepatic Drug Transport: Current Knowledge and Emerging Concepts
Chandra, P., & Brouwer, K. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000026420.79421.8f · Cited by 268 · see citing works
“† Abbreviations used: BQ-123, [cyclo{D-Trp-D-Asp-L-Pro-D-Val-L-Leu}]; BSP, bromosulphophthalein; cAMP, adenosine 3Ј, 5Ј-cyclic monophosphate ; cGMP, guanosine 3Ј,5Ј-cyclic monophosphate; CCK-8, cholecystokinin-8; DHEAS, dehydroepiandrosterone; DPDPE, [D-peni- cillamine 2,5 ]-enkephalin; E 2 17G, estradiol-17(-D-gluc…”
Selective substrates for non-neuronal monoamine transporters.
Gründemann, D., Liebich, G., Kiefer, N., Köster, S., & Schömig, E. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.1.1 · Cited by 266 · see citing works
“However, in intact cells, OCT2 and EMT are pH- and potential-dependent, but a proton gradient does not trans-stimulate transport (Schömig et al., 1992; Gründemann et al., 1997; Kekuda et al., 1998; data not shown).”
InfluentialSelf-citationOrganic Cation Transporters in Health and Disease
Koepsell, H. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.015578 · Cited by 293 · see citing works
“OCT2 (Slc22A2) was cloned from rat (Okuda et al., 1996), OCT3 (SLC22A3) from human (Gründemann et al., 1998) and rat (Kekuda et al., 1998), novel OCT (OCTN) 1 from human (SLC22A4) (Tamai et al., 1997), and OCTN2 from human (SLC22A5) and rat (Wu et al., 1998b) (SlcA5) (Sekine et al., 1998).”
BackgroundInfluentialRoozendaal, B., Quirarte, G. L., & McGaugh, J. L. (2002) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01876.x · Cited by 260 · see citing works
“Corticosterone is a potent inhibitor of this catecholamine uptake through a rapid, nongenomic action (Grundemann et al., 1998).”
BackgroundCiarimboli, G. (2008) · Xenobiotica; the fate of foreign compounds in biological systems · doi:10.1080/00498250701882482 · Cited by 253 · see citing works
“…the third member of the organic cation transporter family, was independently cloned and identified as the extraneuronal monoamine transporter-EMT in the human kidney carcinoma cell line Caki-1 (Gründemann et al. 1998b), in rat placenta (Kekuda et al. 1998) and in rat brain (Wu et al. 1998).”
BackgroundMethodInfluentialMechanistic Links Between Obesity, Diabetes, and Blood Pressure: Role of Perivascular Adipose Tissue
Saxton, S. N., Clark, B., Withers, S., Eringa, E. C., & Heagerty, A. M. (2019) · Physiological Reviews · doi:10.1152/physrev.00034.2018 · Cited by 277 · see citing works
Daws, L. C. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.10.004 · Cited by 223 · see citing works
““Uptake 2” is thought to be located exclusively on glia (Burgen & Iversen, 1965; Hendley et al., 1970; Henn & Hamberger, 1971; Streich et al., 1996; Gründemann et al., 1998), whereas OCT3 is located predominantly on neurons (Wu et al., 1998; Kristufek et al., 2002; Schmitt et al., 2003; Vialou et…”
Polyspecific cation transporters mediate luminal release of acetylcholine from bronchial epithelium.
Lips, K., Volk, C., Schmitt, B. M., Pfeil, U., Arndt, P., Miska, D., Ermert, L., Kummer, W., & Koepsell, H. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2004-0363oc · Cited by 231 · see citing works
“For injection into Xenopus oocytes, m7G(5 )ppp(5 )G-capped cRNAs were prepared from the cDNAs of OCT1–3 from rat (rOCT1 [11], rOCT2 [12], rOCT3 [13]) and human (hOCT1 [14], hOCT2 [14], hOCT3, also called EMT [15]) using the “mMESSAGE mMACHINE” kit (Ambion, Austin, TX).”
MethodTransporters and Renal Drug Elimination
Lee, W., & Kim, R. B. (2004) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121856 · Cited by 222 · see citing works
Amphoux, A., Vialou, V., Drescher, E., Brüss, M., la Cour, C., Rochat, C., Millan, M., Giros, B., Bönisch, H., & Gautron, S. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.01.005 · Cited by 219 · see citing works
Renal Drug Transporters and Drug Interactions
Ivanyuk, A., Livio, F., Biollaz, J., & Buclin, T. (2017) · Clinical Pharmacokinetics · doi:10.1007/s40262-017-0506-8 · Cited by 221 · see citing works
Cui, M., Aras, R. V., Christian, W. V., Rappold, P., Hatwar, M., Panza, J., Jackson-Lewis, V., Javitch, J., Ballatori, N., Przedborski, S., et al. (2009) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0900358106 · Cited by 213 · see citing works
Transporters at CNS Barrier Sites: Obstacles or Opportunities for Drug Delivery?
Sanchez‐Covarrubias, L., Slosky, L. M., Thompson, B. J., Davis, T. P., & Ronaldson, P. T. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990463 · Cited by 232 · see citing works
Polyspecific organic cation transporters: their functions and interactions with drugs
Koepsell, H. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.05.005 · Cited by 198 · see citing works
Localization of organic cation transporters OCT1 and OCT2 in rat kidney.
Karbach, U., Kricke, J., Meyer-Wentrup, F., Gorboulev, V., Volk, C., Loffing-Cueni, D., Kaissling, B., Bachmann, S., & Koepsell, H. (2000) · AJP - Renal Physiology · doi:10.1152/ajprenal.2000.279.4.f679 · Cited by 209 · see citing works
Stress-induced cognitive dysfunction: hormone-neurotransmitter interactions in the prefrontal cortex
Shansky, R. M., & Lipps, J. (2013) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2013.00123 · Cited by 205 · see citing works
“Corticosterone blocks catecholamine transporters in the PFC (Gründemann et al., 1998), resulting in increased extracellular catecholamine levels.”
BackgroundZwart, R., Verhaagh, S., Buitelaar, M., Popp-Snijders, C., & Barlow, D. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.13.4188-4196.2001 · Cited by 205 · see citing works
“Called extraneuronal monoamine transporter (EMT) in humans and organic cation transporter 3 (OCT3) in rats, the protein is predicted to contain a 12-transmembrane domain structure (18, 36).”
BackgroundChen, L., Pawlikowski, B., Schlessinger, A., More, S. S., Stryke, D., Johns, S., Portman, M., Chen, E., Ferrin, T., Sali, A., et al. (2010) · Pharmacogenetics & Genomics · doi:10.1097/fpc.0b013e32833fe789 · Cited by 203 · see citing works
“In addition to this general detoxification function, the OCT family has also been proposed to represent Uptake2, a catecholamine removal system found in peripheral tissues with sympathetic innervations (4).”
BackgroundEstrogen mediates sex differences in stress-induced prefrontal cortex dysfunction
Shansky, R. M., Glavis-Bloom, C., Lerman, D., McRae, P., Benson, C., Miller, K., Cosand, L., Horvath, T. L., & Arnsten, A. F. T. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001435 · Cited by 200 · see citing works
Interaction of Organic Cations with a Newly Identified Plasma Membrane Monoamine Transporter
Engel, K., & Wang, J. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.016832 · Cited by 200 · see citing works
“, 1997), but for human OCT3, TEA is not (Grundemann et al., 1998) or is a poor substrate (Wu et al.”
BackgroundInfluentialSystems mediating acute glucocorticoid effects on memory consolidation and retrieval
Roozendaal, B. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2003.09.015 · Cited by 184 · see citing works
Duan, H., & Wang, J. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.170142 · Cited by 198 · see citing works
“It is noteworthy that, like TEA, the mechanisms underlying the monoamine selectivity of hOCT3 and hPMAT seemed quite different.”
BackgroundInfluentialArnsten, A. F. T. (2000) · Progress in brain research · doi:10.1016/s0079-6123(00)26014-7 · Cited by 194 · see citing works
Stress-induced reduction in reward-related prefrontal cortex function
Ossewaarde, L., Qin, S., van Marle, H. J. F., van Wingen, G. A., Fernández, G., & Hermans, E. J. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.11.068 · Cited by 172 · see citing works
“Catecholaminergic effects on the brain may moreover be amplified by glucocorticoids, which are released peripherally in response to stress (Grundemann et al., 1998; Roozendaal et al., 2002).”
BackgroundIncreased pituitary and adrenal reactivity in premenopausal women with posttraumatic stress disorder
Rasmusson, A. M., Lipschitz, D. S., Wang, S., Hu, S., Vojvoda, D., Bremner, J. D., Southwick, S. M., & Charney, D. S. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01264-1 · Cited by 182 · see citing works
“…1986; Lupien et al 1998; Newcomer et al 1999), amygdala (Schulkin et al 1998), locus coeruleus (Schulkin et al 1998), and prefrontal cortex (Grundemann et al 1998; Lupien et al 1999), areas of the brain thought to play important roles in the production of symptoms and From the VA…”
BackgroundKoepsell, H., Schmitt, B. M., & Gorboulev, V. (2003) · Springer eBooks · doi:10.1007/s10254-003-0017-x · Cited by 318 · see citing works
Renal drug transporters and their significance in drug–drug interactions
Yin, J.-X., & Wang, J. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.07.013 · Cited by 179
Structure, function, and regional distribution of the organic cation transporter OCT3 in the kidney.
Wu, X., Huang, W., Ganapathy, M. E., Wang, H., Kekuda, R., Conway, S. J., Leibach, F., & Ganapathy, V. (2000) · AJP - Renal Physiology · doi:10.1152/ajprenal.2000.279.3.f449 · Cited by 174 · see citing works
“The genes for OCT1, OCT2, and OCT3 are located very close to each other on chromosome 6 in humans (6, 12).”
BackgroundInfluentialMah, L., Szabuniewicz, C., & Fiocco, A. J. (2015) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000223 · Cited by 206 · see citing works
Baganz, N., Horton, R., Calderon, A., Owens, W. A., Munn, J., Watts, L., Koldzic-Zivanovic, N., Jeske, N., Koek, W., Toney, G., et al. (2008) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0800466105 · Cited by 171 · see citing works
“OCT3 was located most densely in the pyramidal and granule cell layers of the hippocampus and appeared to be contained primarily within the neuronal cell bodies (24, 26, 29).”
BackgroundFridén, M., Bergström, F., Wan, H., Rehngren, M., Ahlin, G., Hammarlund-Udenaes, M., & Bredberg, U. (2011) · Drug Metabolism And Disposition · doi:10.1124/dmd.110.035998 · Cited by 164 · see citing works
“Inhibition of MPP uptake by monensin was more potent than that by D22.”
BackgroundInfluentialChronic Stress Weakens Connectivity in the Prefrontal Cortex: Architectural and Molecular Changes.
Woo, E., Sansing, L. H., Arnsten, A. F. T., & Datta, D. (2021) · Chronic Stress · doi:10.1177/24705470211029254 · Cited by 159 · see citing works
Dynamic network connectivity: a new form of neuroplasticity
Arnsten, A. F. T., Paspalas, C. D., Gamo, N. J., Yang, Y., & Wang, M. (2010) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2010.05.003 · Cited by 160 · see citing works
Dopamine’s Actions in Primate Prefrontal Cortex: Challenges for Treating Cognitive Disorders
Arnsten, A. F. T., Wang, M., & Paspalas, C. D. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010512 · Cited by 149 · see citing works
Boivin, B., Lavoie, C., Vaniotis, G., Baragli, A., Villeneuve, L., Éthier, N., Trieu, P., Allen, B., & Hébert, T. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.03.015 · Cited by 147 · see citing works
“However, there are other non-selective uptake systems such as EMT (extraneuronal monoamine transporter, or OCT3) found in several tissues including heart ([56,57], reviewed in [58]) which could transport catecholamines to intracellular targets.”
BackgroundMcReynolds, J. R., Donowho, K. M., Abdi, A., McGaugh, J. L., Roozendaal, B., & McIntyre, C. K. (2009) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2009.11.005 · Cited by 126 · see citing works
Stress-level cortisol treatment impairs inhibitory control of behavior in monkeys
Lyons, D. M., Lopez, J. M., Yang, C., & Schatzberg, A. F. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-20-07816.2000 · Cited by 144 · see citing works
“These outcomes may reflect glucocorticoid regulation of dopamine release (Thomas et al., 1994; Piazza et al., 1996), extrasynaptic reuptake (Grundemann et al., 1998), or changes in dopamine metabolism (Lindley et al., 1999).”
The Neuroendocrinology of Posttraumatic Stress Disorder: New Directions
Rasmusson, A. M., Vythilingam, M., & Morgan, C. A. (2003) · CNS Spectrums · doi:10.1017/s1092852900008841 · Cited by 144 · see citing works
Bacq, A., Balasse, L., Biała, G., Guiard, B. P., Gardier, A. M., Schinkel, A. H., Louis, F., Vialou, V., Martres, M., Chevarin, C., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.87 · Cited by 144 · see citing works
Placental transporters relevant to drug distribution across the maternal-fetal interface.
Ganapathy, V., Prasad, P., Ganapathy, M. E., & Leibach, F. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39087-1 · Cited by 144 · see citing works
“Recent evidence indicates that OCT3 is identical with the extraneuronal monoamine transporter (uptake2) that has been described functionally as a Na1-and Cl2-independent transport system for monoamines (Grundemann et al., 1998; Wu et al., 1998a).”
BackgroundNeurotransmitter transporters: fruitful targets for CNS drug discovery
Iversen, L. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000728 · Cited by 142 · see citing works
Rasmusson, A. M., Vasek, J., Lipschitz, D. S., Vojvoda, D., Mustone, M. E., Shi, Q., Gudmundsen, G. R., Morgan, C. A., Wolfe, J., & Charney, D. S. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300432 · Cited by 141 · see citing works
“…and neurotransmitter systems thought to be involved in the mediation of PTSD symptoms (Sapolsky, 1985, 1986; McEwen, 2000; Schulkin et al, 1998; Grundemann et al, 1998; Lupien et al, 1998, 1999; Newcomer et al, Online publication: 13 February 2004 at http://www.acnp.org/citations/…”
BackgroundTISSUE DISTRIBUTION AND ONTOGENY OF ORGANIC CATION TRANSPORTERS IN MICE
Alnouti, Y., Petrick, J. S., & Klaassen, C. (2006) · Drug Metabolism And Disposition · doi:10.1124/dmd.105.006932 · Cited by 139 · see citing works
“Oct3 is also called extraneuronal monoamine transporter for its role in the extraneuronal monoamine uptake system (uptake2) (Grundemann et al., 1998; Wu et al., 1998a).”
BackgroundGraf, E. N., Wheeler, R. A., Baker, D. L., Ebben, A. L., Hill, J. E., McReynolds, J. R., Robble, M. A., Vranjkovic, O., Wheeler, D., Mantsch, J. R., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1969-13.2013 · Cited by 129 · see citing works
“PMAT is the least sensitive to corticosterone (Ki 450 M), followed by OCT1 (IC50 150 M), OCT2 (IC50 5 M), and OCT3 (IC50 0.04 – 0.2 M) (Grundemann et al., 1998b; Shang et al., 2003; Gorboulev et al., 2005; Schomig et al., 2006; Duan and Wang, 2010).”
BackgroundInfluentialG Protein-Coupled Receptors in and on the Cell Nucleus: A New Signaling Paradigm?
Boivin, B., Vaniotis, G., Allen, B., & Hébert, T. (2008) · Journal of Receptor and Signal Transduction Research · doi:10.1080/10799890801941889 · Cited by 134 · see citing works
“For example, nonselective catecholamine uptake systems such as extraneuronal monoamine transporter (EMT or OCT3) are found in several tissues [(69,70); reviewed in Ref.”
BackgroundExpression and immunolocalization of the plasma membrane monoamine transporter in the brain
Dahlin, A., Li, X., Kong, W., Hevner, R. F., & Wang, J. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.01.072 · Cited by 127 · see citing works
“Human OCT3 favors epinephrine and NE over 5-HT and DA (Grundemann et al., 1998; Amphoux et al., 2006), and is broadly expressed in a number of tissues, including the liver, heart, placenta, skeletal muscle, kidney, and brain (Grundemann et al.”
BackgroundInfluentialFunctional Analysis of Organic Cation Transporter 3 Expressed in Human Placenta
Sata, R., Ohtani, H., Tsujimoto, M., Murakami, H., Koyabu, N., Nakamura, T., Uchiumi, T., Kuwano, M., Nagata, H., Tsukimori, K., et al. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.086827 · Cited by 123 · see citing works
“Organic cation transporter 3 (OCT3) was first cloned from rat placenta (Kekuda et al., 1998), and its orthologues were also cloned from humans and mice (Grü ndemann et al., 1998; Verhaagh et al., 1999).”
BackgroundInfluentialEpithelial Organic Cation Transporters Ensure pH-Dependent Drug Absorption in the Airway
Horváth, G., Schmid, N., Fragoso, M. A., Schmid, A., Conner, G. E., Salathe, M. A., & Wanner, A. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0230oc · Cited by 111 · see citing works
“Five human organic cation transporters have been cloned to date: the potential dependent organic cation transporters OCT1 (6), OCT2 (7), and OCT3 (8), and the pH-dependent organic cation/carnitine transporters OCTN1 (9) and OCTN2 (10).”
BackgroundInfluentialThe influence of acute stress on the regulation of conditioned fear
Raio, C. M., & Phelps, E. A. (2015) · Neurobiology of Stress · doi:10.1016/j.ynstr.2014.11.004 · Cited by 121 · see citing works
Heise, M., Lautem, A., Knapstein, J., Schattenberg, J., Hoppe-Lotichius, M., Foltys, D., Weiler, N., Zimmermann, A., Schad, A., Gründemann, D., et al. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-109 · Cited by 120 · see citing works
Self-citationRole of solute carriers in response to anticancer drugs
Li, Q., & Shu, Y. (2014) · Molecular and Cellular Therapies · doi:10.1186/2052-8426-2-15 · Cited by 118
“cloned as the extraneuronal monoamine transporter by different groups [46,47].”
BackgroundOrganic cation transporters and their pharmacokinetic and pharmacodynamic consequences.
Choi, M., & Song, I. (2008) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.23.243 · Cited by 118 · see citing works
Gasser, P., Orchinik, M., Raju, I., & Lowry, C. (2009) · The Journal of comparative neurology · doi:10.1002/cne.21921 · Cited by 116 · see citing works
“These properties have led to the suggestion that OCT3 may act as a “second line of defense,” contributing to the clearance of extracellular monoamines that escape the high-affinity presynaptic transporters (Grundemann et al., 1998).”
BackgroundAltered aminergic neurotransmission in the brain of organic cation transporter 3‐deficient mice
Vialou, V., Balasse, L., Callebert, J., Launay, J., Giros, B., & Gautron, S. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05506.x · Cited by 114 · see citing works
“Rat and human OCT3 were shown to be able to transport all aminergic neurotransmitters in cellular expression systems (Grundemann et al. 1998b, 1999; Kekuda et al. 1998; Wu et al. 1998).”
BackgroundRegulation of organic cation transport
Ciarimboli, G., & Schlatter, E. (2005) · Pflügers Archiv · doi:10.1007/s00424-004-1355-5 · Cited by 114 · see citing works
“Three isoforms of OCTs have been identified in rat, mouse and man: OCT1 [23, 24], OCT2 [24, 25, 26] and OCT3 [27, 28, 29].”
BackgroundBottalico, B., Larsson, I., Brodszki, J., Hernandez-Andrade, E., Casslén, B., Maršál, K., & Hansson, S. R. (2004) · Placenta · doi:10.1016/j.placenta.2003.10.017 · Cited by 114 · see citing works
“NM_021977 [24].”
BackgroundNucleoside transporter proteins as biomarkers of drug responsiveness and drug targets
Pastor-Anglada, M., & Pérez-Torras, S. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00013 · Cited by 110 · see citing works
“…the family, there are several subfamilies, which consist of members that cluster together based on sequence homology, including the OATs, the OCTs, and the OCTNs. hOCT1, hOCT2, and hOCT3 are encoded by genes SLC22A1-3 (Koehler et al., 1997; Grundemann et al., 1998; Grundemann and Schomig, 2000).”
BackgroundOrganic Cation Transporter 3 (Slc22a3) Is Implicated in Salt-Intake Regulation
Vialou, V., Amphoux, A., Zwart, R., Giros, B., & Gautron, S. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.5147-03.2004 · Cited by 109 · see citing works
Gründemann, D., Hahne, C., Berkels, R., & Schömig, E. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.044404 · Cited by 109 · see citing works
Self-citationSchmitt, A., Mössner, R., Gossmann, A., Fischer, I., Gorboulev, V., Murphy, D., Koepsell, H., & Lesch, K. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10521 · Cited by 106 · see citing works
“For both EMT and rOCT3, a broad substrate specifity was described (Gründemann et al., 1998; Wu et al., 1998; Kekuda et al., 1998; Rajan et al., 2000).”
BackgroundInfluentialGorboulev, V., Shatskaya, N., Volk, C., & Koepsell, H. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.008821 · Cited by 105 · see citing works
“Like other OCTs, hOCT3 translocates monoamine neurotransmitters.”
InfluentialProperties and Regulation of Organic Cation Transport in Freshly Isolated Human Proximal Tubules*
Pietig, G., Mehrens, T., Hirsch, J., Çetinkaya, I., Piechota, H., & Schlatter, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104617200 · Cited by 104
Working memory-related frontal theta activity is decreased under acute stress
Gärtner, M., Rohde-Liebenau, L., Grimm, S., & Bajbouj, M. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.02.009 · Cited by 103 · see citing works
“Furthermore, it is assumed that the impairing effect of high Ca and Gc concentrations is mutually reinforced (Grundemann et al., 1998).”
BackgroundMolecular mechanism of histamine clearance by primary human astrocytes
Yoshikawa, T., Naganuma, F., Iida, T., Nakamura, T., Harada, R., Mohsen, A. S., Kasajima, A., Sasano, H., & Yanai, K. (2013) · Glia · doi:10.1002/glia.22484 · Cited by 106 · see citing works
“OCT2 was not detected in primary human astrocytes, but OCT3 and PMAT were expressed (Fig.”
BackgroundInfluentialPereira, J. N. D. S., Tadjerpisheh, S., Abed, M. A., Saadatmand, A., Weksler, B., Romero, I., Couraud, P., Brockmöller, J., & Tzvetkov, M. (2014) · AAPS Journal · doi:10.1208/s12248-014-9649-9 · Cited by 100 · see citing works
Regulation of human organic cation transporter hOCT2 by PKA, PI3K, and calmodulin-dependent kinases.
Çetinkaya, I., Ciarimboli, G., Yalçınkaya, G., Mehrens, T., Velic, A., Hirsch, J., Gorboulev, V., Koepsell, H., & Schlatter, E. (2003) · AJP - Renal Physiology · doi:10.1152/ajprenal.00251.2002 · Cited by 98 · see citing works
“In 1997, the first human organic cation transporters were cloned (5, 7, 35, 43, 47).”
BackgroundSchömig, E., Lazar, A., & Gründemann, D. (2006) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-29784-7_8 · Cited by 97 · see citing works
Self-citationRodrigo, G. J. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200410-1415oc · Cited by 98 · see citing works
Pu, Z., Krugers, H. J., & Joëls, M. (2007) · Learning & Memory · doi:10.1101/lm.527207 · Cited by 72 · see citing works
Astroglial dopamine transport is mediated by norepinephrine transporter
Takeda, H., Inazu, M., & Matsumiya, T. (2002) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-002-0640-0 · Cited by 94 · see citing works
Inazu, M., Takeda, H., & Matsumiya, T. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03299.x · Cited by 93 · see citing works
“Furthermore, in this study, RT-PCR data show that mRNA for OCT1, OCT2 and OCT3 was expressed at very low levels in rat astrocytes.”
BackgroundInfluentialFerreira, Z., Fernandes, P., Duma, D., Assreuy, J., Avellar, M. C. W., & Markus, R. (2005) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2004.00191.x · Cited by 92 · see citing works
“This uptake has a higher affinity for adrenaline, when compared with noradrenaline [13], and is blocked by corticosterone through a direct, nongenomic mechanism [15].”
Background
- Authors
- Gründemann, D., Schechinger, B., Rappold, G., & Schömig, E.
- Affiliations
- Heidelberg University (DE)
- Corresponding author
- Gründemann, Dirk
- Venue
- Nature Neuroscience
- Published
- 1998-09
- Volume
- 1
- Issue
- 5
- Pages
- 349-351
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- DOI
- 10.1038/1557
- OpenAlex
- W1493374490
- Cited by
- 374
- References
- 0
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 4 · 2023: 10 · 2022: 13 · 2021: 13 · 2020: 9 · 2019: 11 · 2018: 9 · 2017: 8 · 2016: 16 · 2015: 13 · 2014: 17 · 2013: 25 · 2012: 13
- FWCI
- 5.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- sympathetic innervation, pharmacological characterization
- MeSH terms
- Organic Cation Transporter 3, Amino Acid Sequence, Animals, Carrier Proteins, Cell Line, Chromosome Mapping, Chromosomes, Human, Pair 6, Corticosterone, Humans, Kinetics, Molecular Sequence Data, Myocardium, Norepinephrine, 1-Methyl-4-phenylpyridinium, Organic Cation Transport Proteins, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review